Annual report pursuant to Section 13 and 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity

v3.22.4
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Preferred Stock [Member]
Series A Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance (in shares) at Nov. 29, 2020 1,391 14,852,023   0      
Balance at Nov. 29, 2020 $ 0 $ 15,000 $ 58,581,000 $ 0 $ (50,215,000) $ 28,000 $ 8,409,000
Issuance of common stock pursuant to exercise of stock options (in shares) 0 81,182   0      
Issuance of common stock pursuant to exercise of stock options $ 0 $ 0 104,000 $ 0 0 0 104,000
Issuance of common stock pursuant to vesting of restricted stock units (in shares) 0 35,000   0      
Issuance of common stock pursuant to vesting of restricted stock units $ 0 $ 0 533,000 $ 0 0 0 533,000
Dividends declared on preferred stock $ 0 $ 0 (1,043,000) $ 0 0 0 (1,043,000)
Conversion of preferred stock and accrued dividends to common stock (in shares) (1,391) 5,332,147   0      
Conversion of preferred stock and accrued dividends to common stock $ 0 $ 5,000 1,038,000 $ 0 0 0 1,043,000
Sale of common stock, net of underwriting discount and offering costs (in shares) 0 2,875,000   0      
Sale of common stock, net of underwriting discount and offering costs $ 0 $ 3,000 55,949,000 $ 0 0 0 55,952,000
Stock-based compensation $ 0 $ 0 3,150,000 $ 0 0 0 3,150,000
Warrant exercises (in shares) 0 578,744   0      
Warrant exercises $ 0 1,277,000 $ 0 0 0 1,277,000
Net loss 0 0 0 (3,283,000) 0 (3,283,000)
Foreign exchange translation adjustment $ 0 $ 0 $ 0 0 (44,000) (44,000)
Balance (in shares) at Nov. 30, 2021 0 23,754,096   0      
Balance at Nov. 30, 2021 $ 0 $ 23,000 119,589,000 $ 0 (53,498,000) (16,000) $ 66,098,000
Issuance of common stock pursuant to exercise of stock options (in shares) 0 252,250   0     252,250
Issuance of common stock pursuant to exercise of stock options $ 0 $ 0 461,000 $ 0 0 0 $ 461,000
Issuance of common stock pursuant to vesting of restricted stock units (in shares) 0 12,266   0      
Issuance of common stock pursuant to vesting of restricted stock units $ 0 $ 0 0 $ 0 0 0 0
Stock-based compensation 0 0 5,424,000 0 0 0 5,424,000
Net loss 0 0 0 0 (7,885,000) 0 (7,885,000)
Foreign exchange translation adjustment 0 0 0 0 0 (604,000) (604,000)
Reclassification of stock-based compensation due to modification 0 0 (1,043,000) 0 0 0 (1,043,000)
Settlement of obligation to grant stock options $ 0 $ 0 1,043,000 $ 0 0 0 $ 1,043,000
Repurchase of common shares under Stock Buyback Plan (in shares) 0 0   (2,165,987)     (2,165,987)
Repurchase of common shares under Stock Buyback Plan $ 0 $ 0 0 $ (17,500,000) 0 0 $ (17,499,982)
Balance (in shares) at Nov. 30, 2022 0 24,018,612   (2,165,987)      
Balance at Nov. 30, 2022 $ 0 $ 23,000 $ 125,474,000 $ (17,500,000) $ (61,383,000) $ (620,000) $ 45,994,000